PTGS2 and Parkinson disease: In animal models of Parkinson’s disease, COX-2 activation amplifies the cytotoxic effect by the activation of microglia and produces pro-inflammatory prostaglandins, iNOS, ROS and neurodegeneration (Chauhan et al. 2018; Ardah et al. 2020).